BloodCellsByAlexia

Hi, I’m Alexia, a passionate hematologist Fellow exploring the fascinating world of blood disorders. 💉🩸 #MedicalScience #BloodHealth #HematologistLife

[Andres Gomez @GomezDLeonMD]

TMLI 12Gy is better tolerated than FluMel140, can be done outpatient. #Tandem26 #Leusm #BMTsm

[Héctor A. Vaquera @VaqueraH_md]

Important conclusions were drawn from this study:

1. There's a gigantic room for improvement in outcome definition, selection, and implementation in ITP clinical trials

2. Friendship and brightly kind mentorship are a great motor for science

Happy for this incredible humans

[Andres Gomez @GomezDLeonMD]

Teclistamab doses can be reduced by half, given for a limited time, and remain highly effective for RR MM patients maximizing access.

Look for the TECLISito poster on Sunday at #ASH25

#Shouldvebeenoral #MMsm @rennquevedo @dgomezalmaguer

[Andres Gomez @GomezDLeonMD]

Be on the lookout for the work of our trainees and faculty at #ASH25 @uanl a couple of orals and many posters focused on access, practical implementation and global hematology.

From Monterrey 🇲🇽 to Orlando 🍊see you 🔜

[BloodCellsByAlexia @BloodCellsByAle]

@morcossandino @barbie_context Identificada al 100, hahahahaha

[BloodCellsByAlexia @BloodCellsByAle]

@morcossandino @GomezDLeonMD @MDPIOpenAccess Los invito a leer este interesante review, un análisis profundo sobre los desafíos y oportunidades en el tratamiento de la leucemia mieloide aguda en contextos con acceso limitado a recursos.
¡Muchas felicidades al equipo por este gran trabajo!
#Hematología #LMA

[Michelle🩸 @morcossandino]

🧵 1/9
📢 Just published!
"Advances in the Treatment of AML: Implications for Low- and Middle-Income Countries"
🔓 Open access: https://t.co/3dQONA8BEx
🧬 This thread breaks down key insights—and how they can help improve AML care in resource-limited settings.

[BloodCellsByAlexia @BloodCellsByAle]

@morcossandino @GomezDLeonMD @MDPIOpenAccess Los invito a leer este interesante review, un análisis profundo sobre los desafíos y oportunidades en el tratamiento de la leucemia mieloide aguda en contextos con acceso limitado a recursos.

¡Muchas felicidades al equipo por este gran trabajo!

#Hematología #LMA

[Ahmed Kotb @AhmedKo45911157]

ALL management @ MD Anderson 2025
🔬 Subtype & age-driven
🧬 Ph+ B-ALL: TKI ➕ Chemo/Blina → TKI maintenance
🧪 Ph- B-ALL: HCVAD ➕ Blina ± InO
🧱 T-ALL: HCVAD ➕ Nelarabine ± Venetoclax
⚡ Burkitt: R-hyperCVAD / DA-R-EPOCH
🧫 MRD (NGS) ➡️ guides SCT

#ALL #Leukemia #Hematology

[Dr. AK 🇮🇳 @docakx]

🌟 ANA for diagnosis of connective tissue diseases

[Ahmed Kotb @AhmedKo45911157]

🔬Castleman Disease:A spectrum of lymphoproliferative disorders with systemic inflammation🌡️& lymphadenopathy
✨Types:
1️⃣Unicentric (UCD):Localized lymph node📌,>95% survival
2️⃣Multicentric (MCD): Generalized, HHV8+ or Idiopathic
💡iMCD treatment:
✅Steroids
✅Anti-IL6 Siltuximab

[Andres Gomez @GomezDLeonMD]

Missing San Diego? Read our wrap-up piece for ASH Daily News where @morcossandino and me awarded "Golden Globules" to clinically relevant and widely applicable findings from oral abstracts presented at #ASH24...

Written after watching Gladiator II ⚔️🛡️

https://t.co/6Y8kR90fEB

[BloodCellsByAlexia @BloodCellsByAle]

@Itsinmyblood92 🫰🏻❤️

[Itsinmyblood @Itsinmyblood92]

Alexia is not only a wonderful human being but also a brilliant hematologist with so much to offer. Her insights and dedication are paving the way for incredible advancements in science and patient care.

A true inspiration! #ASH24

@BloodCellsByAle 🩸

[BloodCellsByAlexia @BloodCellsByAle]

Honored to receive the David M. Goldenberg CRTI Abstract Award. Grateful to my mentor @GomezDLeonMD Your dedication and invaluable lessons have been a constant source of inspiration and growth.
@ASH_hematology #ASH24

[Michelle🩸 @morcossandino]

Get a glimpse of what’s ahead at the 10 #ScientificWorkShops: Impossible to Resist 💪🏻🧬 at #ASH24
➡️
https://t.co/TYL7adTRe0

#Hematology #immunonc #geriheme #TcellRX #MEDTwitter #ASHNewsDaily
@ASH_hematology
@GomezDLeonMD
@JuliPerezBot

[AmericanJournalofHematology @AjHematology]

The peripheral blood smear leads to diagnosis in patient with undifferentiated shock, emphasizing its importance in the hematologist's toolkit. https://t.co/cUIvpao1PQ
#hematology #heme #hemepath
@The_heme_story @BloodClotDoc

[Michelle🩸 @morcossandino]

This case highlights the critical role of immunosuppressive therapy, especially in resource-limited settings where newer treatments like caplacizumab aren't readily available.
@BloodCellsByAle @paulo_ug
#Hematology #TTP #GlobalHealth 🩸🩸